v3.22.2.2
Business Combination - Intangible Assets Acquired (Details) - Antares Pharma, Inc
$ in Thousands
May 24, 2022
USD ($)
Business Acquisition [Line Items]  
Estimated fair value of intangible assets acquired $ 987,500
ATRS-1902 (IPR&D)  
Business Acquisition [Line Items]  
Indefinite-lived intangible assets acquired 59,600
Auto Injector technology platform  
Business Acquisition [Line Items]  
Finite-lived intangible assets acquired $ 372,900
Useful life (years) 7 years
XYOSTED proprietary product  
Business Acquisition [Line Items]  
Finite-lived intangible assets acquired $ 277,400
Useful life (years) 10 years
TLANDO product rights  
Business Acquisition [Line Items]  
Finite-lived intangible assets acquired $ 277,600
Useful life (years) 10 years